Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics Inc (AURX)
:AURX
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 608.52K | $ 112.25K | $ 0.00 | $ 0.00 | $ 146.18K |
| Gross Profit | $ 482.43K | $ 93.04K | $ 0.00 | $ 0.00 | $ 31.56K |
| Operating Income | $ -3.17M | $ -3.32M | $ -90.67K | $ -378.06K | $ -969.20K |
| EBITDA | $ -3.06M | $ -3.10M | $ 0.00 | $ -288.20K | $ -879.34K |
| Net Income | $ -3.17M | $ -3.03M | $ -90.67K | $ -139.26K | $ -1.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 928.68K | $ 2.05M | $ 148.43K | $ 151.59K | $ 157.26K |
| Total Assets | $ 1.88M | $ 3.05M | $ 149.93K | $ 153.09K | $ 157.26K |
| Total Debt | $ 255.59K | $ 335.05K | $ 0.00 | $ 0.00 | $ 698.97K |
| Net Debt | $ -673.09K | $ -1.72M | $ -148.43K | $ -151.59K | $ 541.71K |
| Total Liabilities | $ 838.73K | $ 856.02K | $ 672.47K | $ 668.87K | $ 666.50K |
| Stockholders' Equity | $ 1.04M | $ 2.19M | $ -522.54K | $ -515.79K | $ -509.24K |
| Cash Flow | |||||
| Free Cash Flow | $ -3.18M | $ -3.77M | $ -13.00K | $ -9.85K | $ -4.17K |
| Operating Cash Flow | $ -3.17M | $ -3.71M | $ -13.00K | $ -9.85K | $ -4.17K |
| Investing Cash Flow | $ -7.24K | $ -59.99K | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 2.00M | $ 4.46M | $ 1.37T | $ 195.00K | $ 305.00K |
Nuo Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.